In March 2025, the company declared new plans for the direct-to-shopper supplying of its Wegovy weight loss drug. The company founded a brand new pharmacy, referred to as NovoCare, which would demand buyers $499 every month for access to the drug, fewer than 50 percent the cost of the drug via o